ArticleMolecular imaging and biology2011
Detection of hepatic metastases using dual-time-point FDG PET/CT scans in patients with colorectal cancer.
Article in Molecular imaging and biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 74 citations in OpenAlex.
- Quantification of FDG-PET/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer.BMC medical imaging · 2018Trial
- Dynamic changes of FDG uptake and clearance in normal tissues.Molecular imaging and biology · 2013Trial
- Test-Retest Repeatability of Patlak Slopes versus Standardized Uptake Values for Hypermetabolic Lesions and Normal Organs in an Oncologic PET/CT Population.Molecular imaging and biology · 2024Article
- Article
- Tumor to liver maximum standardized uptake value ratio of FDG-PET/CT parameters predicts tumor treatment response and survival of stage III non-small cell lung cancer.BMC medical imaging · 2023Article
- Long Axial Field-of-View PET for Ultra-Low-Dose Imaging of Non-Hodgkin Lymphoma during Pregnancy.Diagnostics (Basel, Switzerland) · 2022Article
- KSNM60 in Clinical Nuclear Oncology.Nuclear medicine and molecular imaging · 2021Review
- Current state of oncologicAsia Oceania journal of nuclear medicine & biology · 2021Article
- Diagnostic Value of Delayed PET/MR in Liver Metastasis in Comparison With PET/CT.Frontiers in oncology · 2021Article
- Usefulness of respiratory-gated PET acquisition during delayedAsia Oceania journal of nuclear medicine & biology · 2021Article
- Does Routine Triple-Time-Point FDG PET/CT Imaging Improve the Detection of Liver Metastases?Diagnostics (Basel, Switzerland) · 2020Article
- Improving the Prognostic Performance of SUVJournal of clinical medicine · 2020Article
- Total Body PET: Why, How, What for?IEEE transactions on radiation and plasma medical sciences · 2020Article
- Article
- The extent to which standardized uptake values reflect FDG phosphorylation in the liver and spleen as functions of time after injection ofEJNMMI research · 2017Article
- Elevated tumor-to-liver uptake ratio (TLR) fromEuropean journal of nuclear medicine and molecular imaging · 2017Article
- Limited Identification of Dual-time-point Positron Emission Tomography/Computed Tomography in Advanced Colorectal Neoplasms.Internal medicine (Tokyo, Japan) · 2017Article
- Standardized Uptake Values from PET/MRI in Metastatic Breast Cancer: An Organ-based Comparison With PET/CT.The breast journal · 2016Article
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe purpose of this study was to determine the most useful parameter of dual-time-point 2-deoxy-2-[¹⁸F]fluoro-D: -glucose positron emission tomography/computed tomography (PET/CT) for detection of hepatic metastases in patients with colorectal cancer. PROCEDURES: Thirty-nine patients had undergone a dual-time-point PET/CT scan and a subsequent histopathological confirmation for a workup of hepatic metastases. Detection rates were compared for visual analysis score, standardized uptake value (SUV), tumor-to-liver uptake ratio (TLR), and percent changes of the SUV and TLR.
resultsOf 91 liver lesions, 86 lesions were confirmed as metastases. The SUV and TLR of metastatic lesions on the delayed images were higher than those on the first scan (p < 0.001). The signal-to-noise ratio of the delayed PET scan was higher than that of the first scan (p < 0.0001). The TLR and SUV of the delayed scan showed the highest detection rates of 92% and 88%, whereas percent changes of SUV and TLR showed the lowest detection rates (51%, 67%). Visual analysis detected 87% on the delayed scan and 77% on the first scan.
conclusionsA delayed scan is more favorable for the detection of hepatic metastases of colorectal cancer, and the TLR on the delayed scan was the most useful parameter.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.